We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$142B
AUM Growth
+$3.42B
Cap. Flow
-$820M
Cap. Flow %
-0.58%
Top 10 Hldgs %
16.16%
Holding
3,283
New
205
Increased
1,550
Reduced
1,318
Closed
145

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$199M
2
AAPL icon
Apple
AAPL
+$192M
3
YHOO
Yahoo Inc
YHOO
+$162M
4
LLY icon
Eli Lilly
LLY
+$161M
5
ORLY icon
O'Reilly Automotive
ORLY
+$147M

Sector Composition

Rank Sector Weight
1 Technology 16.54%
2 Financials 14.86%
3 Healthcare 13.86%
4 Consumer Discretionary 11.24%
5 Industrials 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILA icon
3126
Liberty Latin America Class A
LILA
$1.71B
$3K ﹤0.01%
211
ONIT
3127
Onity Group
ONIT
$292M
$2K ﹤0.01%
49
-16,188
-100% -$768K
AQB icon
3128
AquaBounty Technologies
AQB
$5.97M
$1K ﹤0.01%
4
-181
-98% -$30.9K
SHLD
3129
DELISTED
Sears Holding Corporation
SHLD
$1K ﹤0.01%
108
BTX.WS
3130
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$1K ﹤0.01%
2,121
ADVM
3131
DELISTED
Adverum Biotechnologies
ADVM
-7,353
Closed -$199K
ALT icon
3132
Altimmune
ALT
$587M
-1,689
Closed -$411K
AMSC icon
3133
American Superconductor
AMSC
$1.58B
-37,847
Closed -$260K
APVO icon
3134
Aptevo Therapeutics
APVO
$4.98M
0
-$310K
ARWR icon
3135
Arrowhead Research
ARWR
$12.1B
-175,805
Closed -$325K
AXSM icon
3136
Axsome Therapeutics
AXSM
$10.9B
-31,730
Closed -$124K
CDTX
3137
DELISTED
Cidara Therapeutics
CDTX
-1,953
Closed -$305K
CRDF icon
3138
Cardiff Oncology
CRDF
$72.7M
-1,060
Closed -$88K
DWSN icon
3139
Dawson Geophysical
DWSN
$150M
-84,846
Closed -$449K
DXLG icon
3140
Destination XL Group
DXLG
$31M
-121,423
Closed -$346K
ELDN icon
3141
Eledon Pharmaceuticals
ELDN
$265M
-226
Closed -$31K
EPD icon
3142
Enterprise Products Partners
EPD
$82B
-311,606
Closed -$8.6M
FLGT icon
3143
Fulgent Genetics
FLGT
$504M
-3,605
Closed -$39K
GLOB icon
3144
Globant
GLOB
$1.6B
-69,069
Closed -$2.51M
CBIO
3145
Crescent Biopharma
CBIO
$592M
-309
Closed -$168K
GOOS
3146
Canada Goose Holdings
GOOS
$843M
-76,812
Closed -$1.23M
GSM icon
3147
FerroAtlántica
GSM
$775M
-176,484
Closed -$1.82M
GTE icon
3148
Gran Tierra Energy
GTE
$325M
-16,000
Closed -$422K
HNNA icon
3149
Hennessy Advisors
HNNA
$77.9M
-13,318
Closed -$224K
IMUX icon
3150
Immunic
IMUX
$194M
-194
Closed -$310K

Similar funds

TIAA CREF Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, TIAA CREF Investment Management held 3,283 positions worth $142B, up 2.5% from $139B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

TIAA CREF Investment Management's Q2 2017 filing shows 205 new, 1,550 increased, 1,318 reduced and 145 closed positions. Its largest new stake was DXC Technology: 5,417,750 shares worth $360M. The largest sale was Microsoft, an estimated $199M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • TIAA CREF Investment Management's largest Q2 2017 buy was DXC Technology: 5,417,750 shares worth $360M.
  • TIAA CREF Investment Management added most to Dick's Sporting Goods in Q2 2017, an estimated $184M increase.
  • TIAA CREF Investment Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $199M.
  • TIAA CREF Investment Management fully exited Yahoo Inc in Q2 2017, selling an estimated $162M.
  • TIAA CREF Investment Management's ten largest holdings make up 16% of its $142B portfolio in Q2 2017.
  • TIAA CREF Investment Management opened 205 new positions and closed 145 in Q2 2017.
  • TIAA CREF Investment Management's portfolio value rose 2.5% quarter-over-quarter to $142B.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.